Clinical Trial Update: Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial exploring dose finding and protection assessment for Shigella flexneri 2a Invaplex 50 vaccine; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigellosis

Drugs mentioned

• Invaplex 50 (Invaplex 50)
• Shigella flexneri 2a Invaplex 50 vaccine (Invaplex 50 vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Shigellosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-09-11